促销时间表 Mirati Therapeutics, Inc.
先进的时间表
简单图表
关于公司 Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc., онкологическая компания на клинической стадии, разрабатывает продукты-кандидаты для лечения генетических и иммунологических промоторов рака в Соединенных Штатах. 更多详情IPO date | 2004-06-29 |
---|---|
ISIN | US60468T1051 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.mirati.com |
Цена ао | 58.7 |
每日价格变化: | 0% (58.7) |
---|---|
每周价格变化: | 0% (58.7) |
每月价格变化: | 0% (58.7) |
3个月内价格变化: | 0% (58.7) |
六个月内的价格变化: | 0% (58.7) |
每年价格变化: | 0% (58.7) |
3年内价格变化: | -45.44% (107.58) |
5年内价格变化: | -36.75% (92.8) |
10年价格变化: | 0% (58.7) |
年初以来价格变化: | 0% (58.7) |
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
交易日期 | 披露日期 | 内幕 | 类型 | 价格 | 体积 | 数量 | 分享最多, % | 之后分享, % | 文档 |
---|---|---|---|---|---|---|---|---|---|
02.06.2023 | 02.06.2023 | Stelzer Laurie Chief Financial Officer |
销售 | 37.06 | 172 218 | 4647 | 0 | -0.01 | 关联 |
28.11.2022 | 28.11.2022 | BAUM CHARLES M President,Founder,Head of R&D |
销售 | 100 | 6 925 600 | 69256 | 0 | -0.13 | 关联 |
28.11.2022 | 28.11.2022 | BAUM CHARLES M President,Founder,Head of R&D |
购买 | 17.41 | 1 205 750 | 69256 | 0 | 0.13 | 关联 |
07.01.2022 | 07.01.2022 | REED VICKIE S SVP, Chief Accounting Officer |
销售 | 135.94 | 46 899 | 345 | 0 | 0 | 关联 |
07.01.2022 | 07.01.2022 | Hickey Benjamin EVP, Chief Commercial Officer |
销售 | 135.94 | 266 986 | 1964 | 0 | 0 | 关联 |
03.12.2021 | 03.12.2021 | BAUM CHARLES M President & Head of R&D |
销售 | 133.2 | 6 287 570 | 47204 | 0 | -0.09 | 关联 |
03.12.2021 | 03.12.2021 | BAUM CHARLES M President & Head of R&D |
购买 | 8.49 | 400 762 | 47204 | 0 | 0.09 | 关联 |
机构 | 体积 | 分享, % |
---|---|---|
RTW Investments LP | 6768514 | 9.65 |
Avoro Capital Advisors LLC | 6666666 | 9.5 |
EcoR1 Capital, LLC | 5748399 | 8.19 |
Vanguard Group Inc | 5699632 | 8.13 |
Blackrock Inc. | 3544311 | 5.05 |
Wellington Management Group, LLP | 3319922 | 4.73 |
Boxer Capital, LLC | 3201440 | 4.56 |
Aviva Holdings Ltd. | 3135966 | 4.47 |
State Street Corporation | 2745968 | 3.91 |
Morgan Stanley | 2462132 | 3.51 |
ETF | 分享, % | 本年盈利能力, % | 股息, % |
---|---|---|---|
AdvisorShares Alpha DNA Equity Sentiment ETF | 1.26 | 0 | |
ProShares UltraShort Nasdaq Biotechnology | 0.46 | -40.36 | 1.76 |
JPMorgan BetaBuilders U.S. Small Cap Equity Fund | 0.00512 | 24.75 | 1.59225 |
Nuveen ESG Small-Cap ETF | 0.00157 | 13.91 | 1.41019 |
Dimensional U.S. Core Equity 2 ETF | 0.00074 | 30.76 | 1.47098 |
Dimensional US Core Equity Market ETF | 0.00032 | 30.98 | 1.40618 |
Columbia Research Enhanced Value ETF | 0.00006 | 28.02 | 2.60097 |
Columbia Research Enhanced Core ETF | 0.00002 | 33.58 | 1.60295 |
导师 | 职称 | 支付 | 出生年份 |
---|---|---|---|
Dr. Charles M. Baum M.D., Ph.D. | Founder, President, CEO & Director | 1.07M | 1958 (67 年) |
Dr. James G. Christensen Ph.D. | Executive VP & Chief Scientific Officer | 1.76M | 1968 (57 年) |
Dr. Kelly Covello Ph.D. | VP & Head of Medical Affairs | N/A | |
Mr. Benjamin J. Hickey M.B.A. | Chief Commercial Officer | 769.03k | 1975 (50 年) |
Mr. Michael E. Paolucci | Chief People Officer | N/A | 1960 (65 年) |
Dr. Alan Bart Sandler M.D. | Executive VP & Chief Medical Officer | 591k | 1957 (68 年) |
Mr. John B. Moriarty Jr., J.D. | Chief Legal Officer & Corporate Secretary | N/A | 1968 (57 年) |
Mr. Aaron Ondrey | Chief Financial Officer | N/A | 1976 (49 年) |
Ms. Betsy Gelfand CPA | Chief Accounting Officer, Principal Accounting Officer & VP of Finance | N/A | |
Mr. Peter Lee | Chief Compliance Officer | N/A |
地址: United States, San Diego, CA , 3545 Cray Court - 在 Google 地图中打开, 打开 Yandex 地图
网站: http://www.mirati.com
网站: http://www.mirati.com